Literature DB >> 21482177

A framework for global surveillance of antibiotic resistance.

Hajo Grundmann1, Keith P Klugman, Timothy Walsh, Pilar Ramon-Pardo, Betuel Sigauque, Wasif Khan, Ramanan Laxminarayan, Andreas Heddini, John Stelling.   

Abstract

The foreseen decline in antibiotic effectiveness explains the needs for data to inform the global public health agenda about the magnitude and evolution of antibiotic resistance as a serious threat to human health and development. Opportunistic bacterial pathogens are the cause of the majority of community and hospital-acquired infections worldwide. We provide an inventory of pre-existing regional surveillance programs in the six WHO regions which should form the underpinning for the consolidation of a global network infrastructure and we outline the structural components such as an international network of reference laboratories that need to be put in place to address the void of these crucial data. In addition we suggest to make use of existing Health and Demographic Surveillance Sites (HDSS) to obtain crucial information from communities in resource limited settings at household level in low- and middle-income countries in Asia and Africa. For optimising the use of surveillance data for public health action i.e. priority setting for new drug development, comparative quantification of antibiotic effectiveness at local, national, regional and global level and identification of the action gaps can be helpful.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482177     DOI: 10.1016/j.drup.2011.02.007

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  36 in total

1.  How can we fight against antimicrobial- resistant bacteria in the World Health Organization Western Pacific Region?

Authors:  Yoshiaki Gu; Mitsuo Kaku
Journal:  Western Pac Surveill Response J       Date:  2012-07-30

Review 2.  Antimicrobial use and antimicrobial resistance in food animals.

Authors:  Wenguang Xiong; Yongxue Sun; Zhenling Zeng
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-25       Impact factor: 4.223

3.  Isolation and Structural Elucidation of Brevibacillin, an Antimicrobial Lipopeptide from Brevibacillus laterosporus That Combats Drug-Resistant Gram-Positive Bacteria.

Authors:  Xu Yang; En Huang; Chunhua Yuan; Liwen Zhang; Ahmed E Yousef
Journal:  Appl Environ Microbiol       Date:  2016-04-18       Impact factor: 4.792

4.  Influence of Proline Substitution on the Bioactivity of Mammalian-Derived Antimicrobial Peptide NK-2.

Authors:  Jiexi Yan; Xiaolei Liang; Chang Liu; Yuemei Cheng; Lanxia Zhou; Kairong Wang; Li Zhao
Journal:  Probiotics Antimicrob Proteins       Date:  2018-03       Impact factor: 4.609

5.  Optimizing a Screening Protocol for Potential Extended-Spectrum β-Lactamase Escherichia coli on MacConkey Agar for Use in a Global Surveillance Program.

Authors:  Megan E Jacob; Shivaramu Keelara; Awa Aidara-Kane; Jorge R Matheu Alvarez; Paula J Fedorka-Cray
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

Review 6.  The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria.

Authors:  Federico Perez; Maria Virginia Villegas
Journal:  Curr Opin Infect Dis       Date:  2015-08       Impact factor: 4.915

7.  Metagenomic and network analysis reveal wide distribution and co-occurrence of environmental antibiotic resistance genes.

Authors:  Bing Li; Ying Yang; Liping Ma; Feng Ju; Feng Guo; James M Tiedje; Tong Zhang
Journal:  ISME J       Date:  2015-04-28       Impact factor: 10.302

8.  The evolutionary histories of clinical and environmental SHV β-lactamases are intertwined.

Authors:  Robert L Dorit; Christopher M Roy; Sandra M Robinson; Margaret A Riley
Journal:  J Mol Evol       Date:  2013-07-17       Impact factor: 2.395

Review 9.  Human, animal and environmental contributors to antibiotic resistance in low-resource settings: integrating behavioural, epidemiological and One Health approaches.

Authors:  Emily K Rousham; Leanne Unicomb; Mohammad Aminul Islam
Journal:  Proc Biol Sci       Date:  2018-04-11       Impact factor: 5.349

10.  Role of the Outer Membrane and Porins in Susceptibility of β-Lactamase-Producing Enterobacteriaceae to Ceftazidime-Avibactam.

Authors:  Jean-Marie Pagès; Sabine Peslier; Thomas A Keating; Jean-Philippe Lavigne; Wright W Nichols
Journal:  Antimicrob Agents Chemother       Date:  2015-12-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.